STUDY15: a multicentre, randomised trial comparing combination gemcitabine/carboplatin and hydroxychloroquine versus carboplatin/etoposide therapy for stage IV small-cell lung cancer (SCLC).
Authors
Ngai, YHackshaw, A
Blackhall, Fiona H
Greystoke, A
Ahmed, S
El-Khouly, F
Farrelly, L
Jenner, R
Bremner, F
Salomoni, P
Hewish, M
Morris, E
Lee, S
Affiliation
CRUK & UCL Cancer Trials Centre, University College London, LondonIssue Date
2018-01
Metadata
Show full item recordCitation
STUDY15: a multicentre, randomised trial comparing combination gemcitabine/carboplatin and hydroxychloroquine versus carboplatin/etoposide therapy for stage IV small-cell lung cancer (SCLC) 2018, 115:S84 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(18)30215-0Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500218302150Type
Meetings and ProceedingsLanguage
enISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(18)30215-0